INFERGEN (interferon alfacon-1)
Company: AmgenApproval Status: Approved October 1997
Treatment for: hepatitis C
Areas: Immune System
General Information
A launch has taken place in the U.S. of Amgen's consensus interferon (interferon alfacon-1, INFERGEN) for the treatment of chronic hepatitis C virus infection.
INFERGEN Drug Information
The Infergen drug information shown above is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.
